ENDRA Life Sciences Financial Overview
ENDRA Life Sciences's market cap is currently $5.82M. The company's EPS TTM is $-2.1; its P/E ratio is -0.01; ENDRA Life Sciences is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-1.23. See an overview of income statement, balance sheet, and cash flow financials.
